91 related articles for article (PubMed ID: 3197595)
21. Effects of lidoflazine and mioflazine against potassium and veratrine induced shape changes in isolated rat cardiac myocytes.
Ver Donck L; Liu GS; Vandeplassche G; Borgers M
Basic Res Cardiol; 1987; 82(1):74-81. PubMed ID: 3593184
[TBL] [Abstract][Full Text] [Related]
22. [The effect of lidoflazine on the excitation process in the resting and stress ECG in coronary patients (author's transl)].
Lehmann HU; Scholle J; Hochrein H
MMW Munch Med Wochenschr; 1974 Nov; 116(46):2019-26. PubMed ID: 4141058
[No Abstract] [Full Text] [Related]
23. [Effect of agents used in the therapy of acute ischemic heart disease on the histomorphological changes in the myocardium in acute dystrophy].
Nikulin AA; Chernov IP
Farmakol Toksikol; 1979; 42(4):371-6. PubMed ID: 477957
[TBL] [Abstract][Full Text] [Related]
24. [Defibrillating effects of lidoflazine in auricular fibrillation].
Zemánková J; Dvorák I; Blaha M; Bravený P
Vnitr Lek; 1981 Apr; 27(4):345-50. PubMed ID: 7293024
[No Abstract] [Full Text] [Related]
25. [Clinical study of Lidoflazine in 50 patients with ischemic cardiopathy].
Warembourg H; Delebecque H; Peltier JM
Lille Med; 1972; 17():Suppl 5:1073-7. PubMed ID: 4639555
[No Abstract] [Full Text] [Related]
26. [Severe hypertrophic myocardiopathy in newborn infants. Intra-erythrocyte calcium and the effect of lidoflazine, a calcium-channel inhibitor. Apropos of 2 cases].
Vliers A; Stijns-Cailteux M; Lintermans J; Trémouroux-Wattiez M; Godfraind T
Arch Mal Coeur Vaiss; 1984 May; 77(5):496-502. PubMed ID: 6428345
[TBL] [Abstract][Full Text] [Related]
27. [Exercise tolerance and working capacity of the left ventricle after pharmacologic disruption of atrial fibrillation and restoration of sinus rhythm].
Zikmund M; Hůla J
Vnitr Lek; 1981 Oct; 27(10):970-5. PubMed ID: 7314537
[No Abstract] [Full Text] [Related]
28. [Acute effect of lidoflazine on the electrocardiographic agitation discharge in atrial frequency stimulation (studies on patients with stress-induced coronary insufficiency)].
Lehmann HU; Beck OA; Hochrein H
Z Kardiol; 1975 May; 64(5):396-410. PubMed ID: 1189535
[TBL] [Abstract][Full Text] [Related]
29. [Anti-arrhythmic action of lidoflazine].
Zini C; Domenici M
Torace; 1976 Dec; 19(1-4):100-5. PubMed ID: 1052720
[No Abstract] [Full Text] [Related]
30. Cardioprotective effects of mioflazine during 1 h normothermic global ischaemia in the canine heart.
Flameng W; Xhonneux R; Van Belle H; Borgers M; Van de Water A; Wouters L; Wijnants J; Thoné F; Van Daele P; Janssen PA
Cardiovasc Res; 1984 Sep; 18(9):528-37. PubMed ID: 6467270
[TBL] [Abstract][Full Text] [Related]
31. [Effect of lidoflazine on auricular arrhythmia].
Abastado M; Mevel JP; Robert JM
Nouv Presse Med; 1977 Oct; 6(34):3119. PubMed ID: 917827
[No Abstract] [Full Text] [Related]
32. [Clinical study of lidoflazine].
De Mey D; Dernier J; Block P; Paesmans M
Brux Med; 1970 Sep; 50(9):639-43. PubMed ID: 5510365
[No Abstract] [Full Text] [Related]
33. Postinfarction exercise capacity after lidoflazine treatment or physical training.
Degré S; Lenaers A; Messin R; Vandermoten P; Salhadin P; Limage M; Denolin H
Cardiology; 1979; 64(1):35-47. PubMed ID: 365332
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacology and clinical effects of lidoflazine].
Janssen PA
Actual Pharmacol (Paris); 1970; 23():135-61. PubMed ID: 4948983
[No Abstract] [Full Text] [Related]
35. [Conversion of atrial fibrillation in sinus rhythm with lidoflazine and DC impulses].
Cikos J; Topalov V; Trifunović S; Vodopivec Z
Med Pregl; 1982; 35(9-10):341-4. PubMed ID: 7185026
[No Abstract] [Full Text] [Related]
36. [Combined use of propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)].
Beck OA; Hochrein H
Dtsch Med Wochenschr; 1980 Sep; 105(36):1243-6. PubMed ID: 6159147
[TBL] [Abstract][Full Text] [Related]
37. Lidoflazine (Clinium) for angina?
Drug Ther Bull; 1983 Apr; 21(7):27-8. PubMed ID: 6851868
[No Abstract] [Full Text] [Related]
38. [Use of lidoflazine (Clinium) as an anti-arrhythmia agent].
Niederland V; Poór F
Orv Hetil; 1979 Mar; 120(9):525-7. PubMed ID: 424229
[No Abstract] [Full Text] [Related]
39. [Proceedings: Lidoflazin--a coronary drug with anti-fibrillatory properties].
Lehmann HU; Hochrein H
Z Kardiol; 1975; Suppl 2():115. PubMed ID: 1199323
[No Abstract] [Full Text] [Related]
40. [Therapeutic study of Lidoflazine in coronary arteriosclerosis complicated by angina pectoris].
Benyamine R; Jouve A
Mars Med; 1972; 109(4):317-9. PubMed ID: 5070408
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
